NCT05068193View on ClinicalTrials.gov

"A Clinical Trial to Compare the Pharmacokinetics and Bioequivalence of BR2008 With BR2008-1 in Healthy Volunteers"

PHASE1CompletedINTERVENTIONAL
Enrollment

57

Participants

Timeline

Start Date

September 6, 2021

Primary Completion Date

November 28, 2021

Study Completion Date

January 6, 2022

Conditions
Hepatocellular Carcinoma
Interventions
DRUG

BR2008-1 (R)

After fasting at least 10 hours, two tablets of BR2008-1 will be administered orally with 150mL of water around 8 a.m.

DRUG

BR2008 (T)

After fasting at least 10 hours, one tablet of BR2008 will be administered orally with 150mL of water around 8 a.m.

Trial Locations (1)

Unknown

Bestian Hospital, Osŏng

Sponsors
All Listed Sponsors
lead

Boryung Pharmaceutical Co., Ltd

INDUSTRY